SCHEMBL10155154

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL10156217	0.90	BACE1 (0.52)	RAB9ABACE1ALDH1A1
	SCHEMBL10157117	0.90	BACE1 (0.56)	NPC1RAB9ASMN1; SMN2BACE1CYP1A2
	SCHEMBL10157767	0.84	BACE1 (0.53)	BACE1
	SCHEMBL10157518	0.83	BACE1 (0.54)	BACE1
	SCHEMBL14144328	0.83	BACE1 (0.54)	BACE1
	SCHEMBL10156635	0.82	BACE1 (0.52)	NPC1RAB9ASMN1; SMN2BACE1NAMPT
	SCHEMBL10155476	0.82	HIF1A (0.52)	BACE1MAPTNAMPT
	SCHEMBL10156589	0.81	BACE1 (0.57)	BACE1
	SCHEMBL10155887	0.81	BACE1 (0.59)	NPC1RAB9ASMN1; SMN2BACE1MAPT
	SCHEMBL10157285	0.81	HDAC2 (0.47)	NPC1RAB9ASMN1; SMN2BACE1NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.